What is the current price and intraday move for GV.PA stock?

GV.PA stock trades at **€0.0018** intraday on 11 Mar 2026, up **5.88%** with a day range of **€0.0015–€0.0020** and volume **38,489,238** shares, well above its average volume.

How does Meyka AI grade GV.PA stock and what does it mean?

Meyka AI rates GV.PA **62.66 (Grade B, HOLD)**. The score accounts for S&P 500 and sector comparison, financial growth, metrics, forecasts and analyst views. This is informational and not financial advice.

What price targets and forecast exist for GV.PA stock?

Meyka AI's forecast model projects **€0.0040** (implied upside **122.22%**). Price-target scenarios: conservative **€0.0025**, base **€0.0040**, optimistic **€0.0100**. Forecasts are model-based projections, not guarantees.

What are the main risks when trading GV.PA stock?

Main risks include very low market cap (**€693,191**), thin liquidity, negative EPS **-0.11**, and volatile spreads. Use small position sizes and strict stop-losses for intraday trades.

EU Stocks

GV.PA Genomic Vision SA EURONEXT up 5.88% intraday 11 Mar 2026: heavy volume signals active trade

ByDanny Kontos March 11, 2026

GV.PA stock is trading at €0.0018 on EURONEXT in Europe after an intraday rise of 5.88% on 11 Mar 2026, led by a volume spike of 38,489,238 shares. The move follows thin liquidity and a low market cap of €693,191, which amplifies intraday swings. Traders should watch the day range €0.0015–€0.0020 and the 50-day average €0.004844 for short-term context. We examine financial metrics, volume drivers, Meyka AI grading, and a model forecast to frame a most-active trading view.